NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER
NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER
Authorised
- Turkey rhinotracheitis virus, strain PL21, Live
Product identification
Medicine name:
NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER
NEMOVAC
Active substance:
- Turkey rhinotracheitis virus, strain PL21, Live
Target species:
-
Chicken (layer hen)
-
Chicken (for reproduction)
-
Chicken (broiler)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain PL21, Live2.30log10 tissue culture infective dose 501.00unit(s)
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Oral use
- Chicken (layer hen)
-
All relevant tissues0day
-
- Chicken (for reproduction)
-
All relevant tissues0day
-
- Chicken (broiler)
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Box of ten1000-dose bottle,
- Box of one 2000-dose bottle
- Box of ten 2000-dose bottles
- Box of one 5000-dose bottles
- Box of ten 5000-dose bottles
- Box of one 1000-dose bottle
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/5721646 5/2001
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0353/001
Concerned member states:
-
Austria
-
Germany
-
Greece
-
Ireland
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023
Combined File of all Documents
English (PDF)
Download Published on: 19/02/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/06/2023
How useful was this page?: